Literature DB >> 15947260

Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.

Marta Rubiera1, José Alvarez-Sabín, Marc Ribo, Joan Montaner, Esteban Santamarina, Juan F Arenillas, Rafael Huertas, Pilar Delgado, Francisco Purroy, Carlos A Molina.   

Abstract

BACKGROUND AND
PURPOSE: We aimed to determine clinical and hemodynamic predictors of early reocclusion (RO) in stroke patients treated with intravenous tissue plasminogen activator (tPA).
METHODS: We studied 142 consecutive stroke patients with a documented middle cerebral artery (MCA) occlusion treated with intravenous tPA. All patients underwent carotid ultrasound and transcranial Doppler (TCD) examination before tPA bolus. National Institutes of Health Stroke Scale (NIHSS) scores were performed at baseline and serially for <24 hours. TCD monitoring of MCA recanalization (RE) and RO was performed during the first 2 hours after tPA bolus and repeated when clinical deterioration occurred <24 hours after documented RE in absence of intracranial hemorrhage.
RESULTS: After 1 hour of tPA administration, RE occurred in 84 (61%) patients (53 partial, 31 complete). Of these, 21 (25%) patients worsened after an initial improvement and 17 (12%) of them showed RO on TCD. RO was identified at a mean time of 65+/-55 minutes after documented RE. RO was associated (P=0.034) with a lower degree of 24-hour NIHSS score improvement than sustained RE, and a higher modified Rankin scale score at 3 months (P=0.002). Age older than 75 years (P=0.012), previous antiplatelet treatment (P=0.048), baseline NIHSS score >16 points (P=0.009), higher leukocytes count (P=0.042), beginning of RE <60 minutes after tPA bolus (P=0.039), and ipsilateral severe carotid stenosis/occlusion (P=0.001) were significantly associated with RO. In a logistic regression model, NIHSS score >16 at baseline (odds ratio [OR], 7.1; 95% CI, 1.3 to 32) and severe ipsilateral carotid disease (OR, 13.3; 95% CI, 3.2 to 54) remained as independent predictors of RO.
CONCLUSIONS: Stroke severity and ipsilateral severe carotid artery disease independently predict RO after tPA-induced MCA RE.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947260     DOI: 10.1161/01.STR.0000170711.43405.81

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  51 in total

Review 1.  The endovascular management of intracranial vascular disease including the MERCI device.

Authors:  Chirag D Gandhi; David M Johnson; Aman B Patel
Journal:  Curr Cardiol Rep       Date:  2007-03       Impact factor: 2.931

2.  Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice.

Authors:  Mohamad El Amki; Dominique Lerouet; Marie Garraud; Fei Teng; Virginie Beray-Berthat; Bérard Coqueran; Benoît Barsacq; Charlotte Abbou; Bruno Palmier; Catherine Marchand-Leroux; Isabelle Margaill
Journal:  Mol Neurobiol       Date:  2018-04-12       Impact factor: 5.590

3.  Penumbra system: a novel mechanical thrombectomy device for large-vessel occlusions in acute stroke.

Authors:  Z Kulcsár; C Bonvin; V M Pereira; S Altrichter; H Yilmaz; K O Lövblad; R Sztajzel; D A Rüfenacht
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-17       Impact factor: 3.825

Review 4.  Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke.

Authors:  Ming Yang; Xiaochuan Huo; Zhongrong Miao; Yongjun Wang
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

Review 5.  Role of transcranial Doppler ultrasonography in evaluation of patients with cerebrovascular disease.

Authors:  Vijay K Sharma; Georgios Tsivgoulis; Annabelle Y Lao; Andrei V Alexandrov
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

6.  Mechanical thrombectomy in tandem occlusion: procedural considerations and clinical results.

Authors:  H Lockau; T Liebig; T Henning; V Neuschmelting; H Stetefeld; C Kabbasch; F Dorn
Journal:  Neuroradiology       Date:  2014-11-18       Impact factor: 2.804

7.  Emergent extracranial internal carotid artery stenting and mechanical thrombectomy in acute ischaemic stroke.

Authors:  Ankit Mishra; Hannah Stockley; Tony Goddard; Hemant Sonwalker; Siddhartha Wuppalapati; Tufail Patankar
Journal:  Interv Neuroradiol       Date:  2015-05-05       Impact factor: 1.610

8.  Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke.

Authors:  Hélène N David; Benoît Haelewyn; Jean-Jacques Risso; Nathalie Colloc'h; Jacques H Abraini
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

9.  A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial.

Authors:  S M Zinkstok; M Vermeulen; J Stam; R J de Haan; Y B Roos
Journal:  Trials       Date:  2010-05-12       Impact factor: 2.279

10.  Intra-arterial thrombolysis of occluded middle cerebral artery by use of collateral pathways in patients with tandem cervical carotid artery/middle cerebral artery occlusion.

Authors:  O Ozdemir; M Bussière; A Leung; I Gulka; D Lee; R Chan; J D Spence; D Pelz
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-04       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.